Tag: Intermittent claudication

paclitaxel

UK MHRA update: Paclitaxel-coated device increased mortality risk is withdrawn for...

Following a review, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has updated guidance on the use of paclitaxel-coated devices stating that such...

Stenting of the SFA for intermittent claudication yields quality-of-life benefits out...

In a recent study of patients with intermittent claudication (IC) caused by isolated superficial femoral artery (SFA) lesions, researchers found that primary stenting conferred...